Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ly Tu

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Arthritis Research & Therapy|January 6, 2022
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse modelsCindy Orvain, Anne Cauvet, Alexis Prudent, et al.
American Journal of Respiratory and Critical Care Medicine|June 4, 2015
Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary HypertensionVéronique Freund-Michel, Marcelina Cardoso Dos Santos, Christophe Guignabert, et al.
Hypertension (Dallas, Tex. : 1979)|January 21, 2026
BMP9 Modulates IL-33 Signaling to Mitigate EndMT in Pulmonary Arterial HypertensionClarissa Becher, Esmee J Groeneveld, Rozenn Quarck, et al.
ERJ Open Research|November 12, 2025
The activin pathway in chronic thromboembolic pulmonary hypertension: a potential biomarker for residual pulmonary hypertension after endarterectomyAlessandra Cuomo, Corinne Normand, Raphaël Thuillet, et al.
Annals of the Rheumatic Diseases|January 4, 2023
Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysisSébastien Sanges, Lisa Rice, Ly Tu, et al.
International Journal of Molecular Sciences|December 21, 2018
Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary FibrosisSven Günther, Jennifer Bordenave, Thông Hua-Huy, et al.
Oncotarget|November 2, 2017
A genome-wide association analysis identifies <i>PDE1A</i>|<i>DNAJC10</i> locus on chromosome 2 associated with idiopathic pulmonary arterial hypertension in a Japanese populationMai Kimura, Yuichi Tamura, Christophe Guignabert, et al.
European Journal of Pharmacology|March 13, 2023
AMPK activation by metformin protects against pulmonary hypertension in rats and relaxes isolated human pulmonary arteryHeba Abdelazeem, Ly Tu, Raphaël Thuillet, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2022
Driving Role of Interleukin-2-Related Regulatory CD4+ T Cell Deficiency in the Development of Lung Fibrosis and Vascular Remodeling in a Mouse Model of Systemic SclerosisCamelia Frantz, Anne Cauvet, Aurélie Durand, et al.
Journal of Clinical Medicine|April 30, 2020
Lower Plasma Melatonin Levels Predict Worse Long-Term Survival in Pulmonary Arterial HypertensionZongye Cai, Theo Klein, Laurie W Geenen, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Arthritis Research & Therapy|January 6, 2022
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse modelsCindy Orvain, Anne Cauvet, Alexis Prudent, et al.
American Journal of Respiratory and Critical Care Medicine|June 4, 2015
Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary HypertensionVéronique Freund-Michel, Marcelina Cardoso Dos Santos, Christophe Guignabert, et al.
Hypertension (Dallas, Tex. : 1979)|January 21, 2026
BMP9 Modulates IL-33 Signaling to Mitigate EndMT in Pulmonary Arterial HypertensionClarissa Becher, Esmee J Groeneveld, Rozenn Quarck, et al.
ERJ Open Research|November 12, 2025
The activin pathway in chronic thromboembolic pulmonary hypertension: a potential biomarker for residual pulmonary hypertension after endarterectomyAlessandra Cuomo, Corinne Normand, Raphaël Thuillet, et al.
Annals of the Rheumatic Diseases|January 4, 2023
Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysisSébastien Sanges, Lisa Rice, Ly Tu, et al.
International Journal of Molecular Sciences|December 21, 2018
Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary FibrosisSven Günther, Jennifer Bordenave, Thông Hua-Huy, et al.
Oncotarget|November 2, 2017
A genome-wide association analysis identifies <i>PDE1A</i>|<i>DNAJC10</i> locus on chromosome 2 associated with idiopathic pulmonary arterial hypertension in a Japanese populationMai Kimura, Yuichi Tamura, Christophe Guignabert, et al.
European Journal of Pharmacology|March 13, 2023
AMPK activation by metformin protects against pulmonary hypertension in rats and relaxes isolated human pulmonary arteryHeba Abdelazeem, Ly Tu, Raphaël Thuillet, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2022
Driving Role of Interleukin-2-Related Regulatory CD4+ T Cell Deficiency in the Development of Lung Fibrosis and Vascular Remodeling in a Mouse Model of Systemic SclerosisCamelia Frantz, Anne Cauvet, Aurélie Durand, et al.
Journal of Clinical Medicine|April 30, 2020
Lower Plasma Melatonin Levels Predict Worse Long-Term Survival in Pulmonary Arterial HypertensionZongye Cai, Theo Klein, Laurie W Geenen, et al.
Pageof 9